Table 1 Demographic and clinical characteristics
From: Severe and critical COVID-19 in a tertiary center in Colombia, a retrospective cross-sectional study
Variable | n = 158 (%) | Patients discharged alive n = 101(%) | In-hospital death n = 57(%) | p | Patients not needing invasive mechanical ventilation, n = 95(%) | Patients requiring invasive mechanical ventilation, n = 63(%) | p |
|---|---|---|---|---|---|---|---|
Age, mean, SD; | 63.8 (29 to 96), SD 14.6 | 61 (29 to 96), SD 14.4 | 68.8 (37 to 93), SD12.4 | 0.00 | 63.2 (29 to 96), SD 16.2 | 64.6 (37 to 91), SD 10.7 | 0.048 |
> 60 years old | 94 (59.5) | 51 (50.5) | 43 (75.4) | 0.002 | 54 (56.8) | 40 (63.5) | 0.4 |
Male | 112 (70.9) | 70 (69.3) | 42 (73.7) | 0.56 | 66 (69) | 46 (73) | 0.6 |
Days of hospital stay, median (IQR) | 9 (5–15) | 8 (5.5–14) | 10 (4–17) | 0.8 | 7 (5–12) | 14 (6–22) | 0.005 |
In-hospital death | 57 (36) | 9 (9) | 48 (76) | 0.001 | |||
ICU admission | 104 (65.8) | 51 (50.5) | 53 (93) | 0.001 | 41 (43) | 63 (100) | |
ICU days, median (IQR) | 9 (4–15) | 8 (4–14) | 11 (4–16.5) | 0.5 | 6 (3.5–9) | 12 (5–17) | 0.004 |
Acute kidney injury | 57 (36.1) | 18 (17.8) | 39 (68.4) | 0.001 | 16 (16) | 41 (65) | 0.001 |
Shock requiring vasoactive support | 61 (38.6) | 12 (11.9) | 49 (86) | 0.001 | 2 (2) | 59 (93) | 0.001 |
High blood pressure | 95 (60) | 56 (55) | 39 (68) | 0.11 | 52 (54.7) | 43 (68.3) | 0.08 |
Diabetes mellitus type 2 | 77 (48.7) | 45 (44) | 32 (56) | 0.16 | 42 (44) | 35 (55) | 0.1 |
Obesity | 42 (26.6) | 27 (26) | 15 (26) | 0.95 | 21 (22.1) | 21 (33.3) | 0.11 |
COPD | 26 (16.5) | 10 (9.9) | 16 (28) | 0.003 | 12 (12.6) | 14 (22.2) | 0.11 |
Stage 3 and 4 CKD | 12 (7.6) | 4 (4) | 8 (14) | 0.029 | 5 (5.3) | 7 (11.1) | 0.22 |
Current or former smoking | 35 (22) | 17 (16.8) | 18 (31.6) | 0.032 | 17 (17.9) | 18 (28.6) | 0.11 |